Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis
- PMID: 10644906
- DOI: 10.1159/000045536
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis
Abstract
Background/aims: Data have appeared suggesting that an impairment of renal tubular secretion is present in liver cirrhosis, even in the absence of a clinically evident renal dysfunction. To address this question, we evaluated the renal clearance of N(1)-methylnicotinamide (NMN), a marker of the renal secretory function, in healthy subjects and patients with liver cirrhosis of increasing severity, but with a normal glomerular filtration rate.
Methods: The renal clearances of endogenous NMN, inulin, and creatinine were measured in 14 normal subjects and in two groups of age-matched cirrhotic patients (10 Child A and 10 Child C). In 6 subjects, 2 per group, the concentration dependence of the NMN clearance was also studied, following an oral nicotinamide load.
Results: Contrary to expectations, the renal NMN clearance increased in cirrhotic patients, in relation to the severity of liver disease (r = 0.83 with Pugh's score; p < 0.001). The NMN-to-inulin clearance ratio increased from a control value of 2.2 +/- (SD) 0.4 to 3.1 +/- 0.2 and 5.2 +/- 0.9 in Child A and Child C cirrhotics, respectively (p < 0.001 for all comparisons), indicating that NMN was completely cleared from plasma in the latter patients. Consistently, the analysis of the concentration dependence of the renal NMN clearance revealed the presence of a carrier-mediated reabsorption which apparently was no longer operating in the decompensated patients. Discriminant analysis showed that renal NMN clearance, and NMN-to-creatinine and NMN-to-inulin clearance ratios could all distinguish between the three study groups, with sensitivities and specificities equal or greater than 90%.
Conclusions: Contrary to previous proposals, NMN is not a probe of general validity for renal tubular secretion. In particular, due to an imbalance between secretion and reabsorption, its renal clearance in liver cirrhosis cannot be used to determine the degree of tubular secretion of which an individual is capable. However, renal NMN clearance appears to be a very sensitive marker of the severity of liver dysfunction in cirrhosis. The potentialities of this renal parameter as a diagnostic and prognostic test in liver cirrhosis deserve further study.
Copyright 2000 S. Karger AG, Basel
Similar articles
-
Estimation of renal tubular secretion in man, in health and disease, using endogenous N-1-methylnicotinamide.Nephron. 1992;60(1):12-6. doi: 10.1159/000186698. Nephron. 1992. PMID: 1531378
-
Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.Clin Sci (Lond). 2002 Jan;102(1):91-8. Clin Sci (Lond). 2002. PMID: 11749665
-
Estimation of renal secretory function for organic cations by endogenous N1-methylnicotinamide in rats with experimental renal failure.J Pharmacokinet Biopharm. 1984 Feb;12(1):23-42. doi: 10.1007/BF01063609. J Pharmacokinet Biopharm. 1984. PMID: 6235362
-
[Glomerular filtration markers in pediatrics].Rev Med Suisse Romande. 2002 Dec;122(12):625-30. Rev Med Suisse Romande. 2002. PMID: 12611189 Review. French.
-
Dose adjustment in patients with liver disease.Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005. Drug Saf. 2005. PMID: 15924505 Review.
Cited by
-
Urinary Excretion of N1-methyl-2-pyridone-5-carboxamide and N1-methylnicotinamide in Renal Transplant Recipients and Donors.J Clin Med. 2020 Feb 6;9(2):437. doi: 10.3390/jcm9020437. J Clin Med. 2020. PMID: 32041099 Free PMC article.
-
Effect of dronedarone on renal function in healthy subjects.Br J Clin Pharmacol. 2007 Dec;64(6):785-91. doi: 10.1111/j.1365-2125.2007.02998.x. Epub 2007 Jul 27. Br J Clin Pharmacol. 2007. PMID: 17662087 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical